NDC codes

406279 NDC codes with hospital pricing data in the network.

• NDC 00074-3977-03 — STERILE WATER, SALINE AND/OR DEXTROSE, DILUENT/FLUSH, 10 ML (7 hospitals, 24–240 samples)
• NDC 00469-0872-02 — Adenosine injection, 1 mgAI (21 hospitals, 24–240 samples)
• NDC 00517-4810-10 — Nitroglycerin injection in dextrose solutionAI (30 hospitals, 24–240 samples)
• NDC 59746-0002-04 — Methylprednisolone 8 mg tabletsAI (157 hospitals, 24–240 samples)
• NDC 67457-0815-04 — Clindamycin 150 mg/mL injectionAI (146 hospitals, 24–240 samples)
• NDC 00009-0746-35 — Depo-Provera injection, 1 mLAI (127 hospitals, 24–240 samples)
• NDC 00703-6801-04 — Medroxyprogesterone 150 mg/mL injectionAI (60 hospitals, 24–240 samples)
• NDC 44567-0400-10 — Meropenem 500 mg IV injectionAI (199 hospitals, 24–240 samples)
• NDC 66647-4121-21 — LORAZEP 100MG/NS 100MLPMX (1 hospital, 177–240 samples)
• NDC 0053768032 — Human albumin 25% intravenous solutionAI (22 hospitals, 24–240 samples)
• NDC 0053768033 — Human albumin 25% intravenous solutionAI (21 hospitals, 24–240 samples)
• NDC 0548960200 — Neostigmine methylsulfate 1 mg/mL injectionAI (42 hospitals, 24–240 samples)
• NDC 0641615001 — Neostigmine methylsulfate injection, 0.5 mg/mLAI (56 hospitals, 24–240 samples)
• NDC 0641615010 — NEOSTIGMINE METHYLSULFATE 0.5 MG/ML INTRAVENOUS SOLUTIONAI (58 hospitals, 24–240 samples)
• NDC 0944049301 — Human albumin 25% intravenous solutionAI (42 hospitals, 24–240 samples)
• NDC 0944049302 — Human albumin 25% intravenous solutionAI (40 hospitals, 24–240 samples)
• NDC 1353369221 — Human albumin 25% intravenous solutionAI (21 hospitals, 24–240 samples)
• NDC 4202318801 — Neostigmine methylsulfate injection, 0.5 mg/mLAI (40 hospitals, 24–240 samples)
• NDC 4202318810 — Neostigmine methylsulfate 0.5 mg/mL injectionAI (41 hospitals, 24–240 samples)
• NDC 4202318901 — NEOSTIGMINE METHYLSULFATE 1 MG/ML INTRAVENOUS SOLUTIONAI (50 hospitals, 24–240 samples)
• NDC 4202318910 — NEOSTIGMINE METHYLSULFATE 1 MG/ML INTRAVENOUS SOLUTIONAI (49 hospitals, 24–240 samples)
• NDC 4359852911 — NEOSTIGMINE METHYLSULFATE 1 MG/ML INTRAVENOUS SOLUTIONAI (48 hospitals, 24–240 samples)
• NDC 4359852936 — NEOSTIGMINE METHYLSULFATE 1 MG/ML INTRAVENOUS SOLUTIONAI (49 hospitals, 24–240 samples)
• NDC 4359894511 — Neostigmine methylsulfate 1 mg/mL injection syringeAI (45 hospitals, 24–240 samples)
• NDC 4359894558 — Neostigmine methylsulfate 1 mg/mL intravenous syringeAI (44 hospitals, 24–240 samples)
• NDC 4420625105 — Human albumin 25% intravenous solutionAI (30 hospitals, 24–240 samples)
• NDC 4420625110 — Human albumin 25% intravenous solutionAI (24 hospitals, 24–240 samples)
• NDC 4420625190 — Albumin 25% intravenous solutionAI (28 hospitals, 24–240 samples)
• NDC 4420625191 — Human albumin 25% intravenous solutionAI (21 hospitals, 24–240 samples)
• NDC 5024203706 — Tenecteplase 50 mg intravenous injectionAI (28 hospitals, 24–240 samples)
• NDC 5024212047 — Tenecteplase injection for strokeAI (74 hospitals, 24–240 samples)
• NDC 6155332633 — Neostigmine methylsulfate 1 mg/mL intravenous syringeAI (21 hospitals, 24–240 samples)
• NDC 6155332670 — Neostigmine methylsulfate injection syringeAI (20 hospitals, 24–240 samples)
• NDC 6229533285 — Neostigmine methylsulfate 1 mg/mL injectionAI (20 hospitals, 24–240 samples)
• NDC 6332341310 — Neostigmine methylsulfate 0.5 mg/mL IV solutionAI (40 hospitals, 24–240 samples)
• NDC 6332341536 — Neostigmine methylsulfate 1 mg/mL injectionAI (42 hospitals, 24–240 samples)
• NDC 6332358282 — Glucagon 1 mg/mL injectionAI (40 hospitals, 24–240 samples)
• NDC 6332358313 — Glucagon injection, 1 mgAI (40 hospitals, 24–240 samples)
• NDC 6332359303 — Glucagon injection 1 mg/mL solutionAI (86 hospitals, 24–240 samples)
• NDC 6332359603 — Glucagon injection, 1 mg/mL solutionAI (48 hospitals, 24–240 samples)
• NDC 6332359611 — Glucagon injection, 1 mg per mL solutionAI (46 hospitals, 24–240 samples)
• NDC 6332359613 — Glucagon injection for low blood sugar, 1 mg/mLAI (62 hospitals, 24–240 samples)
• NDC 6420825123 — Human albumin 25% intravenous solutionAI (20 hospitals, 24–240 samples)
• NDC 6420825127 — Albumin 25% intravenous solutionAI (24 hospitals, 24–240 samples)
• NDC 6420825128 — Albumin 25% intravenous solutionAI (23 hospitals, 24–240 samples)
• NDC 6851652160 — Human albumin 25% IV solutionAI (39 hospitals, 24–240 samples)
• NDC 6851652161 — Human albumin 25% intravenous solutionAI (47 hospitals, 24–240 samples)
• NDC 6851652162 — Human albumin 25% intravenous solutionAI (45 hospitals, 24–240 samples)
• NDC 6851652164 — Human albumin 25% intravenous solutionAI (36 hospitals, 24–240 samples)
• NDC 6851652167 — Human albumin 25% intravenous solutionAI (30 hospitals, 24–240 samples)